Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis
- 1 October 2015
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 29 (5) , 853-873
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-NetOrphanet Journal of Rare Diseases, 2013
- An exploratory epidemiological study of Langerhans cell histiocytosisPediatric Blood & Cancer, 2012
- Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective studyOrphanet Journal of Rare Diseases, 2011
- Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans CellsThe Journal of Immunology, 2010
- Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinosidePediatric Blood & Cancer, 2009
- Lung Transplantation for Pulmonary Langerhans' Cell Histiocytosis: A Multicenter AnalysisTransplantation, 2006
- Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunctionEuropean Journal of Cancer, 2005
- Endocrine involvement in pediatric-onset langerhans' cell histiocytosis: a population-based studyThe Journal of Pediatrics, 2004
- Epidemiologic study of Langerhans cell histiocytosis in childrenThe Journal of Pediatrics, 1997
- Histiocytosis X—an analysis of prognostic factorsThe Journal of Pediatrics, 1975